Mipsol
Pharmacovigilance, medical information and quality consulting for pharmaceutical companies and service providers
Highlights
- New on EvolcAdded 2026-11-14
About Mipsol
MIPSOL provides medical information, pharmacovigilance and quality services, including safety system support, audits, inspection readiness, document preparation and training.
It serves human and veterinary pharmaceutical companies and service providers through one-off projects, long-term engagements and ad-hoc consulting. The company was established in 2018 and is registered in London, United Kingdom.
Product: Consulting and support services for pharmacovigilance, medical information, quality, audits, inspection readiness and training.
Jobs at Mipsol
Leadership
- Sarah Hall · DirectorSource: company website
More consulting & professional services companies
Mirad Studios
Strategic communication advisory for organisations in transition: positioning, leadership and internal communication, contentYoung companyNew on EvolcMirai Capital Partners
Independent advisory for family principals, family offices, and institutions navigating capital, governance, and succession decisionsYoung companyNew on EvolcMiratec Solutions
Fractional CIO and IT advisory services for charities, hospices, nonprofits and growing businessesYoung companyNew on EvolcMiriskmedia
Health, safety and security consulting and ScreenSkills-accredited training for film and TV productionsYoung companyNew on EvolcMirror Sales Consultancy, Coaching Services and Business
Sales consultancy and coaching for businesses seeking help with sales processes, customer relationships and field teamsNew on EvolcMissang
Strategic advisory, stakeholder engagement and technology implementation for organisations working across the UK, Africa and the Middle EastNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.